Brca2 Mutation Risk

BRCA2 Mutation Risk is a genetic predisposition assessment that quantifies the elevated likelihood of developing breast cancer in individuals carrying a pathogenic variant in the BRCA2 gene, distinguished from other hereditary cancer risks by its specific association with BRCA2-related tumor suppressor dysfunction.

431

Publications

43.2K

Citations

3.7K

Authors

1.2K

Institutions

Publications per year

2017–2026

76

Authors

3.7K

  1. SA
    Steven A. Narod

    University of Toronto, Canada

    60 publications · 6.4K citations

    37

    h-index

  2. JL
    Jan Lubiński

    Pomeranian Medical University, Poland

    48 publications · 4.9K citations

    34

    h-index

  3. SL
    Susan L. Neuhausen

    City of Hope, United States

    49 publications · 6.8K citations

    34

    h-index

  4. DF
    Douglas F. Easton

    University of Cambridge, United Kingdom

    38 publications · 5.3K citations

    31

    h-index

  5. FJ
    Fergus J. Couch

    Mayo Clinic, United States

    40 publications · 4.7K citations

    30

    h-index

1–5 of 3.7K

Venues

  1. Breast Cancer Research and Treatment

    45 publications · 1.9K citations

    24

    h-index

  2. JNCI Journal of the National Cancer Institute

    18 publications · 5.2K citations

    18

    h-index

  3. British Journal of Cancer

    BJC · 21 publications · 1.3K citations

    17

    h-index

  4. Journal of Clinical Oncology

    16 publications · 3K citations

    15

    h-index

  5. Gynecologic Oncology

    14 publications · 1.1K citations

    14

    h-index

1–5